Global IPO markets made steady gains in 2024, with IPO proceeds increasing compared to the previous year as the high interest ...

Cocoa extract supplementation among older adults had no effect overall on the occurrence of age-related macular degeneration ...

Haleon launched a share buyback programme of up to £330m on Friday, representing the remaining portion of the £500m allocated ...

The Global Smoking Cessation and Nicotine De-Addiction Products Market is valued at approximately USD 24.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.77% ...

Kotak Alternate Asset Managers have announced an investment of ₹1,050 crore in Tirupati Medicare Ltd, a contract development ...

Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth.

Haleon has named Nathalie Gerschtein as president North America, following Lisa Paley’s announcement to step down from her ...

AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...

Pfizer divested 7.3% remaining stake in Haleon, or approximately 662 million shares, to institutional investors and Haleon itself for £3.85 per ordinary share (around £2.5 billion). Pfizer sold ...

Per a previous share buyback plan, Pfizer sold around 44.14 million shares worth approximately $220 million (£170 million) directly to Haleon. Haleon was a consumer health joint venture (JV), an ...